Suppr超能文献

癌胚抗原:一种评估新型冠状病毒肺炎严重程度和预后的潜在生物标志物。

Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19.

作者信息

Chen Qianqian, Kong Hui, Qi Xu, Ding Wenqiu, Ji Ningfei, Wu Chaojie, Huang Chaolin, Wu Wenjuan, Huang Mao, Xie Weiping, Liu Yun, Tang Jinhai

机构信息

Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Division of Intensive Care Unit, Wuhan Jin Yin-tan Hospital, Wuhan, China.

出版信息

Front Med (Lausanne). 2020 Oct 6;7:579543. doi: 10.3389/fmed.2020.579543. eCollection 2020.

Abstract

Corona Virus Disease 2019 (COVID-19) has become a serious pandemic disease worldwide. Identification of biomarkers to predict severity and prognosis is urgently needed for early medical intervention due to high mortality of critical cases with COVID-19. This retrospective study aimed to indicate the values of carcinoembryonic antigen (CEA) in evaluating the severity and prognosis of COVID-19. We included 46 death cases from intensive care unit and 68 discharged cases from ordinary units with confirmed COVID-19 of Wuhan Jin Yin-tan Hospital from January 1 to March 22, 2020. Laboratory and radiologic data were analyzed retrospectively. All patients were followed up until April 10, 2020. COVID-19 patients in the death group had significantly higher CEA levels (ng/ml) than discharged group (14.80 ± 14.20 vs. 3.80 ± 2.43, < 0.001). The risk of COVID-19 death increased 1.317 times for each additional 1 ng/ml CEA level (OR = 1.317, 95% CI: 1.099-1.579). The standardized and weighted receiver operating characteristic curve (ROC) analysis adjusted to age, sex, and ferritin levels suggested that the area under the curve (AUC) of the serum CEA levels was 0.808 in discrimination between death cases and discharged cases with COVID-19 ( < 0.001). We found mortality of COVID-19 is associated with elevated CEA levels increased (HR = 1.023, 95% CI: 1.005-1.042), as well as age (HR = 1.050, 95% CI: 1.016-1.086) and ferritin levels (HR = 1.001, 95% CI: 1.001-1.002) by survival analysis of Cox regression model. Among discharged patients, CEA levels were significant lower in moderate cases compared to the severe and critical cases ( = 0.005; OR = 0.488, 95% CI: 0.294-0.808) from binary logistic regression analysis. The AUC of CEA levels was 0.79 in distinguishing moderate cases from discharged COVID-19 patients by standardized and weighted ROC analysis ( < 0.001). A positive correlation between CEA levels and CT scores existed in discharged patients (Correlation Coefficient: 0.687; < 0.001). Elevated CEA levels increased the risk of death from COVID-19 and CEA levels were related to CT scores of the discharged patients positively.

摘要

2019冠状病毒病(COVID-19)已成为全球范围内的严重大流行病。由于COVID-19危重症病例死亡率高,因此迫切需要鉴定生物标志物以预测病情严重程度和预后,从而进行早期医学干预。本回顾性研究旨在指出癌胚抗原(CEA)在评估COVID-19病情严重程度和预后方面的价值。我们纳入了武汉市金银潭医院2020年1月1日至3月22日确诊为COVID-19的46例重症监护病房死亡病例和68例普通病房出院病例。对实验室和影像学数据进行回顾性分析。所有患者随访至2020年4月10日。死亡组COVID-19患者的CEA水平(ng/ml)显著高于出院组(14.80±14.20 vs. 3.80±2.43,<0.001)。CEA水平每增加1 ng/ml,COVID-19死亡风险增加1.317倍(OR = 1.317,95%CI:1.099 - 1.579)。根据年龄、性别和铁蛋白水平进行调整的标准化加权受试者工作特征曲线(ROC)分析表明,血清CEA水平在区分COVID-19死亡病例和出院病例时的曲线下面积(AUC)为0.808(<0.001)。通过Cox回归模型生存分析,我们发现COVID-19死亡率与CEA水平升高相关(HR = 1.023,95%CI:1.005 - 1.042),还与年龄(HR = 1.050,95%CI:1.016 - 1.086)和铁蛋白水平(HR = 1.001,95%CI:’1.001 - 1.002)相关。在出院患者中,二元逻辑回归分析显示,中度病例的CEA水平显著低于重度和危重症病例(P = 0.005;OR = 0.488,95%CI:0.294 - 0.808)。通过标准化加权ROC分析,CEA水平在区分中度病例和COVID-19出院患者时的AUC为0.79(<0.001)。出院患者的CEA水平与CT评分呈正相关(相关系数:0.687;<0.001)。CEA水平升高增加了COVID-19死亡风险,且CEA水平与出院患者的CT评分呈正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07a/7573292/ddf9214ab3cc/fmed-07-579543-g0001.jpg

相似文献

1
Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19.
Front Med (Lausanne). 2020 Oct 6;7:579543. doi: 10.3389/fmed.2020.579543. eCollection 2020.
2
Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID-19.
Biomed Rep. 2022 Feb;16(2):13. doi: 10.3892/br.2021.1496. Epub 2021 Dec 21.
3
The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study.
Medicine (Baltimore). 2021 Aug 13;100(32):e26900. doi: 10.1097/MD.0000000000026900.
5
Prognostic value of the ratio of pretreatment carcinoembryonic antigen to tumor volume in rectal cancer.
J Gastrointest Oncol. 2023 Dec 31;14(6):2395-2408. doi: 10.21037/jgo-23-683. Epub 2023 Dec 27.
9
Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
Med Clin (Barc). 2021 Apr 9;156(7):324-331. doi: 10.1016/j.medcli.2020.11.030. Epub 2020 Dec 25.
10

引用本文的文献

1
Role of Carcinoembryonic Antigen in Severity Assessment and Mortality Prediction in COVID-19 Patients.
Cureus. 2024 Sep 22;16(9):e69894. doi: 10.7759/cureus.69894. eCollection 2024 Sep.
2
The Diagnostic and Predictive Value of Biomarkers for Pulmonary Fibrosis in Patients with Coronavirus Disease 2019.
J Glob Infect Dis. 2024 May 24;16(2):45-53. doi: 10.4103/jgid.jgid_150_23. eCollection 2024 Apr-Jun.
4
Hospital length of stay for COVID-19 patients: a systematic review and meta-analysis.
Multidiscip Respir Med. 2022 Aug 9;17(1):856. doi: 10.4081/mrm.2022.856. eCollection 2022 Jan 12.
6
Tumor marker response to SARS-CoV-2 infection among patients with cancer.
Cancer Med. 2022 Jul;11(14):2865-2872. doi: 10.1002/cam4.4646. Epub 2022 Mar 15.
7
Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID-19.
Biomed Rep. 2022 Feb;16(2):13. doi: 10.3892/br.2021.1496. Epub 2021 Dec 21.
8
Carcinoembryonic Antigen Elevation in a Patient with SARS-CoV-2 and a History of Colon Cancer.
Case Rep Oncol. 2021 Jun 10;14(2):802-805. doi: 10.1159/000515261. eCollection 2021 May-Aug.

本文引用的文献

1
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Front Cell Infect Microbiol. 2020 Jun 12;10:340. doi: 10.3389/fcimb.2020.00340. eCollection 2020.
2
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.
Lancet Respir Med. 2020 Jul;8(7):681-686. doi: 10.1016/S2213-2600(20)30243-5. Epub 2020 May 27.
3
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Lancet Respir Med. 2020 Aug;8(8):807-815. doi: 10.1016/S2213-2600(20)30225-3. Epub 2020 May 15.
4
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons.
Cytokine Growth Factor Rev. 2020 Jun;53:66-70. doi: 10.1016/j.cytogfr.2020.05.002. Epub 2020 May 7.
5
Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway.
Respir Investig. 2020 Jul;58(4):275-284. doi: 10.1016/j.resinv.2020.01.003. Epub 2020 Apr 29.
6
Elevations of serum cancer biomarkers correlate with severity of COVID-19.
J Med Virol. 2020 Oct;92(10):2036-2041. doi: 10.1002/jmv.25957. Epub 2020 Jun 3.
7
Interpretations of "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)".
Chin Med J (Engl). 2020 Jun 5;133(11):1347-1349. doi: 10.1097/CM9.0000000000000866.
9
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.
Mod Pathol. 2020 Jun;33(6):1007-1014. doi: 10.1038/s41379-020-0536-x. Epub 2020 Apr 14.
10
C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
J Med Virol. 2020 Jul;92(7):856-862. doi: 10.1002/jmv.25871. Epub 2020 Apr 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验